Novo Nordisk A/S et al v. Hims & Hers Health, Inc. et al

  1. March 09, 2026

    Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together

    Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the telehealth provider, the companies announced Monday.

  2. February 10, 2026

    Meet The Attys For Novo Nordisk In Hims & Hers GLP-1 Row

    Rodger D. Smith II and Jeremy A. Tigan of Morris Nichols Arsht & Tunnell LLP represent Novo Nordisk in its challenge against telehealth company Hims & Hers Health Inc.

  3. February 10, 2026

    Novo Nordisk Takes On Hims Over Copycat GLP-1 Pill

    Novo Nordisk's patent infringement suit against telehealth company Hims & Hers over an affordable GLP-1 pill is an escalation in the larger battle between obesity drugmakers and compounding pharmacies.

  4. February 09, 2026

    Novo Nordisk Sues Hims & Hers Over Knockoff GLP-1

    Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff version of its GLP-1 medications.